Clearity Caregiver’s Week: Laurie and Jason’s Story

February 18, 2021 2:00 am

When diagnosed, there’s so much to deal with. After years of warning signs and my primary care doctor treating me for a myriad of medical issues, I presented with excruciating torso and belly pain, a distended stomach & difficulty breathing … Read more

Common Genetic Test Often Wrong When Identifying Rare Disease-Causing Variants Such as BRCA1 and BRCA2, Study Says

February 16, 2021 10:00 am

By Sandee LaMotte, CNN

A genetic test used to detect common traits many people share is not reliable in identifying rare disease-causing variations, such as those that can predict breast and ovarian cancer, a new study has found.

The SNP … Read more

Nulliparity, Not ART, Likely Raises Risk of Ovarian Cancer

January 19, 2021 5:00 pm

By Mark L. Fuerst

Women who receive ovarian stimulation for assisted reproductive technology (ART) procedures don’t have an increased risk of developing ovarian cancer when compared to subfertile women who don’t undergo ART, according to a new study.

The results … Read more

CURE Media Group Bolsters Strategic Alliance Partnership Program With 12 New Partners

December 18, 2020 1:00 pm

The Clearity Foundation is proud to announce its partnership with CURE Media Group, opening up many opportunities for us to reach more women and families who can directly benefit from our services. Specifically, having Clearity’s ovarian cancer experts participate in

Read more

Claudia’s Story: Clearity Was My Rock!

November 23, 2020 5:54 pm

Like many women, Claudia knew something wasn’t quite right when she began to experience an unusual pain in her pelvic area and excessive sweating while at work. Later in the night, she ended up in the hospital with emergency surgery, … Read more

Most Cancer Patients Would Join a Clinical Trial if Offered the Chance

October 20, 2020 4:00 pm

By Anne Harding

New findings debunk the conventional wisdom that Black cancer patients are less likely to agree to participate in clinical trials.

Overall, 55% of patients offered trial participation agreed to enroll, and white and Black patients agreed to … Read more

Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest

October 16, 2020 6:00 pm

 Sharon Worcester

“Many physicians would assume that prevention of cancer, especially cancer as serious as ovarian cancer, trumps all other decision making, but when we really listen to high-risk women, they want to have options,” Karen Lu, MD, … Read more

Clearity’s Scientific Director, Dr. Deb Zajchowski, Honored as a 2020 Ovarian Cancer Hero

October 14, 2020 4:02 pm

Clearity’s very own, Dr. Deborah Zajchowski, has been announced as a 2020 Ovarian Cancer Hero!

CURE’s Third Annual Ovarian Cancer Heroes® awards program recognizes individuals for their heroic contributions in the field of ovarian cancer. This year’s annual evening of … Read more

CURE Media Group Announces the 2020 Ovarian Cancer Heroes® Winners

October 12, 2020 9:30 am

CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research that reaches over 1 million patients, has named the winners of its Third Annual Ovarian Cancer Heroes® awards program. The virtual celebration will be held Friday, … Read more

The Clearity Foundation Teams Up With Select Justice To Help Families Impacted By Ovarian Cancer

September 13, 2020 9:00 am

When a loved one is diagnosed with ovarian cancer, it has a profound effect on their lives and their families’ lives. As quickly as the patient receives her diagnosis, her family members immediately slip into caregivers’ roles, often without warning Read more

San Diego County Administration Building Turns Teal on Sept. 1

September 1, 2020 7:00 am

San Diego’s Teal Women Honored in Historic Gesture in Support of Ovarian Cancer Survivors

September is National Ovarian Cancer Awareness Month and, in recognition, the County of San Diego Administration Center building will be turning its lights the color teal.

Read more

Be The Difference Foundation Announces Collaboration With Mary Crowley Cancer Research and The Clearity Foundation to Increase Support For Clinical Trial Participants

July 31, 2020 11:00 am

New “Caring For Her” program facilitates access to clinical trials and psychosocial support services for women with ovarian cancer.

Be The Difference Foundation today announced the launch of its “Caring For Her” program in partnership with Mary Crowley Cancer Research

Read more

If You Feel Something, Say Something

July 28, 2020 5:00 pm

Have you ever had a doctor roll his or her eyes or give you the brushoff after mentioning a health concern? If you’re like many women, it may not have been your imagination. As more and more research comes out … Read more

Universal BRCA Testing Could Prevent Countless Cancer Deaths

July 17, 2020 1:00 pm

By Diana Swift

Population screening found to be cost-effective for higher income countries

Screening entire populations of women for mutations in breast and ovarian cancer susceptibility genes could prevent hundreds of thousands of cases in the U.S., and millions globally, … Read more

Blood Test Detects Dozens of Cancer Types, Often Before Symptoms Emerge

July 13, 2020 5:00 pm

A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%.

By Mark Leiser

A novel blood test accurately detected more than 50 types of cancer with a specificity of 99.3%, according to results … Read more

Certain Recurring Symptoms May Be Linked to Ovarian Cancer

July 13, 2020 2:00 pm

A recent data analysis found that most women diagnosed with ovarian cancer (92%) experienced abdominal and pelvic-related symptoms and visited a physician with this complaint anywhere from six to 70 months prior to diagnosis.

By Ryan McDonald

Data from a … Read more

A White Paper on the Need for Consistent Terms for Testing in Precision Medicine

July 7, 2020 7:00 am

For years, The Clearity Foundation has emphasized the importance of tumor profiles/blueprints for informing decisions about treatment for ovarian cancer. Yet, genetic and tumor biomarker testing are not universally performed despite evidence that positive results in these tests could suggest … Read more

New Test Paves the Way for Tailored Treatment of Deadliest Form of Ovarian Cancer

June 18, 2020 4:00 pm

University of British Columbia (UBC) researchers have led an international team in developing a new test to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for women diagnosed with the … Read more

‘We Have a Job to Do’: Cancer Patients and Their Doctors Carry on With Clinical Trials During Covid-19

June 17, 2020 5:00 pm

By Elizabeth Cooney

Cancer isn’t waiting for Covid-19 to go away. Neither is Karen Howley.

Diagnosed two years ago with advanced ovarian cancer, Howley started on a new experimental drug in mid-March, just as coronavirus case counts were soaring in … Read more